Majewska Lidia, Dorosz Karolina, Kijowski Jacek
ESME Clinic, ul. Lwowska 1/U16, 30-548 Kraków, Poland.
Biological Sciences Department, University of Chicago, Chicago, IL 60637, USA.
Pharmaceutics. 2025 Apr 24;17(5):553. doi: 10.3390/pharmaceutics17050553.
: Hyaluronic acid (HA)-based bioactive hydrogels have emerged as multifunctional platforms for skin bioregeneration. While traditional mesotherapy using multicomponent substances has been widely practiced for improving skin quality, the time-consuming nature of this approach has led to exploration of alternative delivery methods. : This study evaluated the clinical effectiveness of an HA bioactive hydrogel-based bioregeneration system (containing non-stabilized hyaluronic acid and 14 bioactive ingredients) administered via cannula and its impact on facial skin density as assessed by ultrasound imaging. : We conducted a retrospective review of data from 20 female patients aged 30-42 years who received a single cannula-delivered injection of a bioactive hyaluronic acid hydrogel (TEOSYAL Redensity [I]) in the midface region. The formulation combines the structural benefits of hyaluronic acid with the biochemical stimulation provided by amino acids, antioxidants, minerals, and vitamins. Skin density was measured using high-frequency ultrasound at baseline, immediately post-procedure, and at 3-4 weeks follow-up. A control group of seven individuals received no treatment. : Ultrasound assessments revealed a statistically significant increase in skin density (92.7%, < 0.001) within the treated area compared to no significant changes in the control group. This substantial improvement in dermal architecture demonstrates the efficacy of bioactive hydrogels in stimulating fibroblast function and extracellular matrix regeneration. Patient satisfaction was high, with 85% of patients reporting being satisfied or very satisfied. Side effects were minimal, with minor bruising (10%) and transient swelling (15%). : Cannula-delivered bioactive hyaluronic acid hydrogel effectively enhances facial skin density with high patient satisfaction and minimal downtime, demonstrating the potential of advanced hydrogel formulations as multifunctional therapeutic platforms that extend beyond traditional applications into aesthetic and regenerative dermatology.
基于透明质酸(HA)的生物活性水凝胶已成为皮肤生物再生的多功能平台。虽然使用多组分物质的传统中胚层疗法已被广泛用于改善皮肤质量,但这种方法耗时的特性促使人们探索替代给药方法。
本研究评估了通过套管给药的基于HA生物活性水凝胶的生物再生系统(含有非稳定化透明质酸和14种生物活性成分)的临床效果,以及通过超声成像评估其对面部皮肤密度的影响。
我们对20名年龄在30 - 42岁的女性患者的数据进行了回顾性分析,这些患者在中面部区域接受了单次套管注射生物活性透明质酸水凝胶(TEOSYAL Redensity [I])。该配方将透明质酸的结构优势与氨基酸、抗氧化剂、矿物质和维生素提供的生化刺激相结合。在基线、术后即刻以及3 - 4周随访时使用高频超声测量皮肤密度。7名个体组成的对照组未接受治疗。
超声评估显示,与对照组无显著变化相比,治疗区域内皮肤密度有统计学意义的增加(92.7%,< 0.001)。真皮结构的显著改善证明了生物活性水凝胶在刺激成纤维细胞功能和细胞外基质再生方面的功效。患者满意度较高,85%的患者表示满意或非常满意。副作用最小,轻微瘀伤(10%)和短暂肿胀(15%)。
通过套管给药的生物活性透明质酸水凝胶能有效提高面部皮肤密度,患者满意度高且停机时间短,证明了先进水凝胶配方作为多功能治疗平台的潜力,其应用超越了传统领域,延伸至美容和再生皮肤病学。